SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-172020
Filing Date
2007-08-06
Accepted
2007-08-06 16:24:05
Documents
4
Period of Report
2007-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14461
2 PRESS RELEASE dex991.htm EX-99.1 338350
3 TRANSCRIPT OF WEBCAST CONFERENCE CALL dex992.htm EX-99.2 88324
4 GRAPHIC g88577image001_ex991.jpg GRAPHIC 19360
  Complete submission text file 0001193125-07-172020.txt   469585
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 071028183
SIC: 2836 Biological Products, (No Diagnostic Substances)